bpc-157 human clinical trials evidence safety fda status Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review bpc-157 human clinical trials safety

Dosage and administration: usually 0.25 to 2 ml by intramuscular or slow intravenous injection

Optimized Protocol for Selective Fat Metabolism Dosing: Starting dose: 250 mcg per day (subcutaneous injection) Standard dose: 300-500 mcg per day after 1-2 weeks Frequency: Once daily or divided into two doses (morning and early afternoon) Administration: Route: Subcutaneous injection (abdomen, thigh, or upper arm) Timing: Morning fasted state ideal, or 30-60 minutes before cardio Storage: Reconstituted peptide refrigerated, typically stable 30-60 days Cycle Length: 12-16 weeks for initial assessment, with potential for extended protocols based on clinical trial data showing safe use up to 24 weeks

Adults: As a dietary supplement, take one to two capsules per day

They are not for human consumption and are not intended to diagnose, treat, cure, or prevent plantar fasciitis, chronic foot pain, sports injuries, soft tissue injury, inflammation, pain, stiffness, reduced mobility, recovery delay, performance decline, or any medical condition.